title: Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India.
abstract: The healthcare workers having seroprotection at 3 weeks (n = 127) following Pandemic H1N1 2009 influenza vaccination were followed up for antibody persistence. Seroprotection at 12 mo (60.2%) was significantly lower as compared with 3 weeks (74.7%), 3 mo (77.8%) and 6 mo (75.4%). The vaccine provided seroprotection up to one year.
authors.affiliation: National Institute of Virology, Pashan, Pune India. tandale.bv@niv.co.in
authors.forename: Babasaheb V
authors.initials: BV
authors.lastname: Tandale
authors.forename: Shailesh D
authors.initials: SD
authors.lastname: Pawar
authors.forename: Yogesh K
authors.initials: YK
authors.lastname: Gurav
authors.forename: Saurabh S
authors.initials: SS
authors.lastname: Parkhi
authors.forename: Akhilesh C
authors.initials: AC
authors.lastname: Mishra
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006282:Health Personnel; D006801:Humans; D007194:India; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology*; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control* / Q000821:virology*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines